| Frank R Demarco, MD | |
|
1509 W Truman Rd, Independence, MO 64050-3436 | |
| (816) 836-6901 | |
| (816) 836-4460 |
| Full Name | Frank R Demarco |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 31 Years |
| Location | 1509 W Truman Rd, Independence, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982672432 | NPI | - | NPPES |
| 1982672432 | Other | OK | BCBS |
| 100050480A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 14951 (Oklahoma) | Secondary |
| 207P00000X | Emergency Medicine | 57350 (Kentucky) | Secondary |
| 207P00000X | Emergency Medicine | 110013 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Poplar Bluff Regional Medical Center | Poplar bluff, MO | Hospital |
| Jane Phillips Memorial Medical Center, Inc | Bartlesville, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St John Physicians Inc | 2567366495 | 223 |
News Archive
Routing stroke patients directly to designated stroke centres - instead of taking them to the nearest hospital - dramatically increased access to a key clot-busting drug that can reduce stroke disability if given within the first few hours of symptoms, researchers report in Stroke: Journal of the American Heart Association.
Chemed Corporation announced today that the Board of Directors has formally authorized an additional $100 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.
"The Obama administration is expected to propose in its fiscal 2011 budget Monday new funding to combat preventable and tropical diseases, malnutrition and other conditions afflicting the world's poor, as part of a strategy to broaden its approach to global health," the Wall Street Journal reports.
Massachusetts Eye and Ear, Longwood, a new outpatient surgical center at 800 Huntington Avenue in the Longwood/Mission Hill area of Boston, opened today to patients.
Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer management decisions, today announced the presentation of data highlighting how the accuracy of the DecisionDx-Melanoma gene expression profile (GEP) test in patients with Stage II and IIIA melanoma can improve adjuvant clinical trial design at the 2018 Society for Melanoma Research International Congress held in Manchester, England from October 24-27.
› Verified 7 days ago
| Entity Name | St John Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336194406 PECOS PAC ID: 2567366495 Enrollment ID: O20031121000867 |
News Archive
Routing stroke patients directly to designated stroke centres - instead of taking them to the nearest hospital - dramatically increased access to a key clot-busting drug that can reduce stroke disability if given within the first few hours of symptoms, researchers report in Stroke: Journal of the American Heart Association.
Chemed Corporation announced today that the Board of Directors has formally authorized an additional $100 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.
"The Obama administration is expected to propose in its fiscal 2011 budget Monday new funding to combat preventable and tropical diseases, malnutrition and other conditions afflicting the world's poor, as part of a strategy to broaden its approach to global health," the Wall Street Journal reports.
Massachusetts Eye and Ear, Longwood, a new outpatient surgical center at 800 Huntington Avenue in the Longwood/Mission Hill area of Boston, opened today to patients.
Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer management decisions, today announced the presentation of data highlighting how the accuracy of the DecisionDx-Melanoma gene expression profile (GEP) test in patients with Stage II and IIIA melanoma can improve adjuvant clinical trial design at the 2018 Society for Melanoma Research International Congress held in Manchester, England from October 24-27.
› Verified 7 days ago
| Entity Name | Hospitalist Medicine Physicians Of Oklahoma Tcs Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043932486 PECOS PAC ID: 7315315454 Enrollment ID: O20221122001255 |
News Archive
Routing stroke patients directly to designated stroke centres - instead of taking them to the nearest hospital - dramatically increased access to a key clot-busting drug that can reduce stroke disability if given within the first few hours of symptoms, researchers report in Stroke: Journal of the American Heart Association.
Chemed Corporation announced today that the Board of Directors has formally authorized an additional $100 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.
"The Obama administration is expected to propose in its fiscal 2011 budget Monday new funding to combat preventable and tropical diseases, malnutrition and other conditions afflicting the world's poor, as part of a strategy to broaden its approach to global health," the Wall Street Journal reports.
Massachusetts Eye and Ear, Longwood, a new outpatient surgical center at 800 Huntington Avenue in the Longwood/Mission Hill area of Boston, opened today to patients.
Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer management decisions, today announced the presentation of data highlighting how the accuracy of the DecisionDx-Melanoma gene expression profile (GEP) test in patients with Stage II and IIIA melanoma can improve adjuvant clinical trial design at the 2018 Society for Melanoma Research International Congress held in Manchester, England from October 24-27.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Frank R Demarco, MD 1965 Delwin St, Apt. 6, Cape Girardeau, MO 63701-2360 Ph: (918) 284-8831 | Frank R Demarco, MD 1509 W Truman Rd, Independence, MO 64050-3436 Ph: (816) 836-6901 |
News Archive
Routing stroke patients directly to designated stroke centres - instead of taking them to the nearest hospital - dramatically increased access to a key clot-busting drug that can reduce stroke disability if given within the first few hours of symptoms, researchers report in Stroke: Journal of the American Heart Association.
Chemed Corporation announced today that the Board of Directors has formally authorized an additional $100 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.
"The Obama administration is expected to propose in its fiscal 2011 budget Monday new funding to combat preventable and tropical diseases, malnutrition and other conditions afflicting the world's poor, as part of a strategy to broaden its approach to global health," the Wall Street Journal reports.
Massachusetts Eye and Ear, Longwood, a new outpatient surgical center at 800 Huntington Avenue in the Longwood/Mission Hill area of Boston, opened today to patients.
Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer management decisions, today announced the presentation of data highlighting how the accuracy of the DecisionDx-Melanoma gene expression profile (GEP) test in patients with Stage II and IIIA melanoma can improve adjuvant clinical trial design at the 2018 Society for Melanoma Research International Congress held in Manchester, England from October 24-27.
› Verified 7 days ago
Thomas R Coughlin Jr., MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1509 W Truman Rd, Emergency Department, Independence, MO 64050 Phone: 913-469-4244 Fax: 913-469-1939 | |
David R. Gustafson, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3507 Shady Bend Dr, Independence, MO 64052 Phone: 816-651-8631 | |
Dr. Allison Janell Barfuss-walter, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 19600 E 39th St S, Independence, MO 64057 Phone: 816-698-7000 Fax: 816-698-7000 | |
Aulton Dale Chisum, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1509 W Truman Rd, Emergency Department, Independence, MO 64050 Phone: 913-469-1488 Fax: 913-469-1441 | |
Harry E Kleiner, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1509 W Truman Rd, Emergency Department, Independence, MO 64050 Phone: 913-469-4244 Fax: 913-469-1939 | |
Aryn Elizabeth Dixon, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 19600 E 39th St S, Independence, MO 64057 Phone: 816-698-7000 | |
Dr. Michael Raymond Watts, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 19600 E 39th St S, Independence, MO 64057 Phone: 816-698-7000 |